Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Should it, could it be back to the $2 range... Why not.

If the markman goes our way and all our patents are stronger than ever we could potentially see this stock soar. As long as TPL does there job well and aggressively.

It's been said this market is about $ 200 billion. Tap just 5% of that and you got $ 10B divided by two. $ 5B divided by PTSC shares outstanding?

Shares Outstanding5: 406.75M

That's $ 12.29 per share. Heck I'd be happy with 1/3 of that. :)

Andiamo!

Share
New Message
Please login to post a reply